Pulmonx Corporation (LUNG) Profit Margin
Pulmonx Corporation (LUNG) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | -98.47% |
| 2021-12-31 | -100.51% |
| 2022-12-31 | -109.80% |
| 2023-12-31 | -88.60% |
| 2024-12-31 | -67.30% |
| 2025-12-31 | -59.67% |
How LUNG compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| PRGO | Perrigo Company plc | -33.51% |
| IONS | Ionis Pharmaceuticals Inc. | -40.41% |
| OSUR | OraSure Technologies Inc. | -59.76% |
| HBIO | Harvard Bioscience Inc. | -65.51% |
| QTRX | Quanterix Corporation | -77.14% |
These are five companies in the same sector as LUNG with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Pulmonx Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("LUNG", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LUNG | $2.29 | +1.11% | 0.05M |
| 3 | ||||
| 4 | ||||
| 5 |